DE2415079C3 - Verfahren zum Isolieren von Albumin aus Blutplasma - Google Patents

Verfahren zum Isolieren von Albumin aus Blutplasma

Info

Publication number
DE2415079C3
DE2415079C3 DE2415079A DE2415079A DE2415079C3 DE 2415079 C3 DE2415079 C3 DE 2415079C3 DE 2415079 A DE2415079 A DE 2415079A DE 2415079 A DE2415079 A DE 2415079A DE 2415079 C3 DE2415079 C3 DE 2415079C3
Authority
DE
Germany
Prior art keywords
albumin
values
blood plasma
range
heat treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2415079A
Other languages
German (de)
English (en)
Other versions
DE2415079B2 (de
DE2415079A1 (de
Inventor
Christian Froehlich
Waldemar Dr. Schneider
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Armour Pharma GmbH
Original Assignee
Plasmesco AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Plasmesco AG filed Critical Plasmesco AG
Priority to DE2415079A priority Critical patent/DE2415079C3/de
Priority to NLAANVRAGE7503132,A priority patent/NL177886C/xx
Priority to SE7503075A priority patent/SE436649B/xx
Priority to GB12045/75A priority patent/GB1480184A/en
Priority to FR7509054A priority patent/FR2265757B1/fr
Priority to BE154638A priority patent/BE827050A/xx
Priority to ZA00751827A priority patent/ZA751827B/xx
Priority to DK125275A priority patent/DK141523C/da
Priority to AU79474/75A priority patent/AU492194B2/en
Priority to DD185043A priority patent/DD119248A5/xx
Priority to CA223,373A priority patent/CA1038292A/en
Priority to EG169A priority patent/EG11782A/xx
Priority to CH400275A priority patent/CH629819A5/de
Priority to ES436125A priority patent/ES436125A1/es
Priority to PL1975179122A priority patent/PL93587B1/pl
Priority to AT238175A priority patent/AT338977B/de
Priority to SU752117933A priority patent/SU743564A3/ru
Priority to JP3771375A priority patent/JPS5418325B2/ja
Priority to IN691/CAL/1975A priority patent/IN140388B/en
Publication of DE2415079A1 publication Critical patent/DE2415079A1/de
Priority to US05/755,126 priority patent/US4156681A/en
Priority to IN395/CAL/77A priority patent/IN145868B/en
Publication of DE2415079B2 publication Critical patent/DE2415079B2/de
Application granted granted Critical
Publication of DE2415079C3 publication Critical patent/DE2415079C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE2415079A 1974-03-28 1974-03-28 Verfahren zum Isolieren von Albumin aus Blutplasma Expired DE2415079C3 (de)

Priority Applications (21)

Application Number Priority Date Filing Date Title
DE2415079A DE2415079C3 (de) 1974-03-28 1974-03-28 Verfahren zum Isolieren von Albumin aus Blutplasma
NLAANVRAGE7503132,A NL177886C (nl) 1974-03-28 1975-03-17 Werkwijze voor het isoleren van albumine.
SE7503075A SE436649B (sv) 1974-03-28 1975-03-18 Forfarande vid isolering av albumin ur blodplasma
GB12045/75A GB1480184A (en) 1974-03-28 1975-03-21 Process for isolating albumin from blood
FR7509054A FR2265757B1 ( ) 1974-03-28 1975-03-24
BE154638A BE827050A (nl) 1974-03-28 1975-03-24 Werkwijze voor het isoleren van albuminen
ZA00751827A ZA751827B (en) 1974-03-28 1975-03-24 Process for isolating albumin from blood
AU79474/75A AU492194B2 (en) 1974-03-28 1975-03-25 Process of isolating albumin from blood
DK125275A DK141523C (da) 1974-03-28 1975-03-25 Fremgangsmaade til isolering af albumin fra blod,blodprodukterog placentablod
CA223,373A CA1038292A (en) 1974-03-28 1975-03-26 Process for isolating albumin from blood
DD185043A DD119248A5 ( ) 1974-03-28 1975-03-26
EG169A EG11782A (en) 1974-03-28 1975-03-26 Process of isolating albumin from blood
ES436125A ES436125A1 (es) 1974-03-28 1975-03-27 Un procedimiento para aislar albumina de la sangre, produc- tos sanguineos, otros liquidos organicos extractos de teji- dos.
PL1975179122A PL93587B1 ( ) 1974-03-28 1975-03-27
AT238175A AT338977B (de) 1974-03-28 1975-03-27 Verfahren zum isolieren von albumin
CH400275A CH629819A5 (en) 1974-03-28 1975-03-27 Process for the isolation of albumin from human blood plasma
JP3771375A JPS5418325B2 ( ) 1974-03-28 1975-03-28
SU752117933A SU743564A3 (ru) 1974-03-28 1975-03-28 Способ получени альбумина
IN691/CAL/1975A IN140388B ( ) 1974-03-28 1975-04-07
US05/755,126 US4156681A (en) 1974-03-28 1976-12-28 Process for isolating albumin from blood
IN395/CAL/77A IN145868B ( ) 1974-03-28 1977-03-17

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2415079A DE2415079C3 (de) 1974-03-28 1974-03-28 Verfahren zum Isolieren von Albumin aus Blutplasma

Publications (3)

Publication Number Publication Date
DE2415079A1 DE2415079A1 (de) 1975-10-02
DE2415079B2 DE2415079B2 (de) 1979-06-21
DE2415079C3 true DE2415079C3 (de) 1980-02-14

Family

ID=5911480

Family Applications (1)

Application Number Title Priority Date Filing Date
DE2415079A Expired DE2415079C3 (de) 1974-03-28 1974-03-28 Verfahren zum Isolieren von Albumin aus Blutplasma

Country Status (17)

Country Link
JP (1) JPS5418325B2 ( )
AT (1) AT338977B ( )
BE (1) BE827050A ( )
CH (1) CH629819A5 ( )
DD (1) DD119248A5 ( )
DE (1) DE2415079C3 ( )
DK (1) DK141523C ( )
EG (1) EG11782A ( )
ES (1) ES436125A1 ( )
FR (1) FR2265757B1 ( )
GB (1) GB1480184A ( )
IN (1) IN140388B ( )
NL (1) NL177886C ( )
PL (1) PL93587B1 ( )
SE (1) SE436649B ( )
SU (1) SU743564A3 ( )
ZA (1) ZA751827B ( )

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2556733C3 (de) * 1975-12-17 1986-10-02 Armour Pharma GmbH & Co KG, 3440 Eschwege Verfahren zum Isolieren von Albumin aus Blutplasma
DK25877A (da) * 1977-01-21 1978-08-15 Nordisk Insulinlab Fremgangsmaade til udvinding af renset albumin fra blodplasma
DE3307871C2 (de) * 1983-03-05 1986-10-30 R & Z Biologicals S.A. (Pty.) Ltd., Cape Town Verfahren zur Gewinnung von hochreinem Albumin
HUT40311A (en) * 1983-06-03 1986-12-28 Kiskunhalasi Aag Process for producing protein concentrates, blood-curd and nutriments from blood and its elements

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2190437B1 ( ) * 1972-07-05 1975-08-08 Merieux Inst

Also Published As

Publication number Publication date
IN140388B ( ) 1976-10-30
JPS5418325B2 ( ) 1979-07-06
JPS50154413A ( ) 1975-12-12
NL7503132A (nl) 1975-09-30
ES436125A1 (es) 1977-01-01
AU7947475A (en) 1976-09-30
DD119248A5 ( ) 1976-04-12
DK141523C (da) 1980-09-29
NL177886B (nl) 1985-07-16
GB1480184A (en) 1977-07-20
DK141523B (da) 1980-04-14
CH629819A5 (en) 1982-05-14
ZA751827B (en) 1976-02-25
PL93587B1 ( ) 1977-06-30
DE2415079B2 (de) 1979-06-21
SE7503075L ( ) 1975-09-29
DE2415079A1 (de) 1975-10-02
DK125275A ( ) 1975-09-29
SE436649B (sv) 1985-01-14
SU743564A3 (ru) 1980-06-25
AT338977B (de) 1977-09-26
NL177886C (nl) 1985-12-16
EG11782A (en) 1978-03-29
FR2265757B1 ( ) 1979-03-02
BE827050A (nl) 1975-07-16
ATA238175A (de) 1977-01-15
FR2265757A1 ( ) 1975-10-24

Similar Documents

Publication Publication Date Title
DE2333883C3 (de) Verfahren zur Herstellung von hochgereinigtem Humanalbumin
CH633020A5 (de) Verfahren zum gewinnen gereinigten albumins aus blutplasma.
DE2459291C3 (de) Verfahren zur Herstellung eines antihämophiles Globulin A enthaltenden Konzentrats neben einem Prothrombin- Komplex und einer Lösung von lagerstabilen Serumproteinen
EP0106269B2 (de) Verfahren zur Pasteurisierung von antihämophilem Kryopräzipitat (AHK) und danach hergestelltes antihämophiles Kryopräzipitat
DE2433209A1 (de) Hitzestabile plasmaproteinloesungen, verfahren zu ihrer herstellung und arzneipraeparate
DE2403994A1 (de) Herstellung von antisera
DE69133399T2 (de) Methode zur Herstellung von im Wesentlichen monomeren normalen menschlichen Serum-Albumin
DE2732998C2 (de) Verfahren zur Herstellung von Serumalbuminfraktionen
DD296842A5 (de) Verfahren zur herstellung von gereinigten albuminloesungen
DE2734150C3 (de) Verfahren zur Herstellung von Human-Lysozympräparaten
CH633809A5 (de) Verfahren zur herstellung einer serumalbuminfraktion.
DE2415079C3 (de) Verfahren zum Isolieren von Albumin aus Blutplasma
EP0367840A1 (de) Verfahren zur Herstellung eines hochreinen, nicht infektiösen Antihämophiliefaktors mittels Chromatographie
DE2440927C3 (de) Injizierbarer inaktivierter Impfstoff gegen Hepatitis B
DE2515666C3 (de) Piasminreiche Gammaglobulinfraktion, Verfahren zu deren Herstellung und das Verfahrensprodukt enthaltendes Gammaglobulinpräparat
DE68907718T2 (de) Verfahren zur pasteurisierung von wässrigen lösungen von faktor viii.
DE2440926C3 (de) Injizierbarer inaktivierter Impfstoff gegen Hepatitis B und Verfahren zu seiner Herstellung
DE2733923C3 (de) Verfahren zur Gewinnung von Humanalbumin
DE3307871C2 (de) Verfahren zur Gewinnung von hochreinem Albumin
AT271725B (de) Verfahren zur Gewinnung von Gammaglobulin
DE2856939A1 (de) Verfahren zur gewinnung von intravenoes-vertraeglichen gammaglobulinen
DE2333884C3 (de) Verfahren zum Herstellen von hochgereinigtem Humanalbumin
DE1130113B (de) Verfahren zur Abtrennung von therapeutisch verwendbaren, mindestens 80% ª†-Globulin enthaltenden Praeparaten von anderen Blutproteinen
DE1920423B2 (de) Verfahren zur bereitung von stabiler loesung der plasmaeiweisskoerper, des albumins sowie der alpha- und beta-globuline
DD160582A3 (de) Herstellung von albumin unter verwendung von waermeuebertragersystemen

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
EGA New person/name/address of the applicant
OI Miscellaneous see part 1
8327 Change in the person/name/address of the patent owner

Owner name: ARMOUR PHARMA GMBH & CO KG, 3440 ESCHWEGE, DE

AG Has addition no.

Ref country code: DE

Ref document number: 2556733

Format of ref document f/p: P

8327 Change in the person/name/address of the patent owner

Owner name: ARMOUR PHARMA GMBH & CO. KG, 4800 BIELEFELD, DE

8327 Change in the person/name/address of the patent owner

Owner name: ARMOUR PHARMA GMBH, 3440 ESCHWEGE, DE

8339 Ceased/non-payment of the annual fee